Simon Jose - Articles and news items

Stiefel Logo

Stiefel signs worldwide acquisition and license agreement for Toctino®

Industry news, News / 11 June 2012 / GlaxoSmithKline

Stiefel has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica Ltd…


Advanced kidney cancer patients now able to access Votrient®▼ (pazopanib)

Industry news, News / 7 March 2011 / GlaxoSmithKline

Patients living in Scotland with renal cell carcinoma, will have access to a new treatment choice, as Votrient® (pazopanib)…


New treatment choice for advanced kidney cancer patients as Votrient®▼ made available on the NHS

Industry news, News / 23 February 2011 / Packer Forbes Communications

Patients with advanced renal cell carcinoma, can access Votrient® on the NHS…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...